152
Views
44
CrossRef citations to date
0
Altmetric
Original Article

Influenza Vaccination Among Healthy Employees: A Cost-Benefit Analysis

&
Pages 181-185 | Received 11 Nov 1996, Accepted 20 Dec 1996, Published online: 08 Jul 2009

References

  • Immunisation against infectious disease. HMSO, London 1992; 96
  • Influenzavaccination 1995/96. EPI-NYT. Sundhedsstyrelsens meldesystem for smittsomme sygdomme, Uge 39, 1995. Statens Seruminstitut, Denmark 1995
  • Hovi T, Honkanen P, Kuronen T. ja Kansanterveyslaitoksen rokotussuositustyoryhma. Influenssarokotusten käytöstä syksyllä 1996. Suom Lääkäril 1996; 51: 2101–2102
  • Influenzavaccination 1995. Recommendations by the Director General of Public Health. Iceland 1995
  • Influensavaksine til risikogrupperne 1995/96. Norway, Uke 1995, MSIS-Rapport
  • Om influensa och vaccination. Dnr. 33–7662/94, Social-styrelsen, Smittskyddssektionen, Folkhälsoenheten. Sweden 1994
  • Nicholson K G, Snacken R, Palache A M. Influenza immunization policies in Europe and the United States. Vaccine 1995; 13: 365–369
  • Macnair A. The Case for Comprehensive Immunization Programmes. Influenza Monitoring and Information Bureau, Bucks 1991; 25
  • Schoenbaum S C. Economic impact of influenza: the individual's perspective. Am J Med 1987; 82: 26–30, Suppl 6A
  • Sulander P, Karvonen P, Jokinen M. Influenssarokotuksen vaikutus työstäpoissaoloihin. Suom Lääkäril 1977; 32: 537–539
  • Smith J WG, Pollard R. Vaccination against influenza: a five-year study in the Post Office. J Hyg Camb 1979; 83: 157–170
  • Weingarten S, Staniloff H, Ault M, Miles P, Bamberger M, Myer R D. Do hospital employees benefit from the influenza vaccine?. J Gen Intern Med 1988; 3: 32–37
  • Levy E, Levy P. La vaccination centre la grippe des personnes d'aˇge actif (25–64 ans): une etude cout-benefice. Rev Epidém et Santé Publ 1992; 40: 285–295
  • Nichol K L, Lind A, Margolis K L, Murdoch M, McFadden R, Hauge M, Magnan S, Drake M. The effectiveness of vaccination against influenza in healthy, working adults. New Engl J Med 1995; 333: 889–893
  • Helliwell B E, Drummond M F. The costs and benefits of preventing influenza in Ontario's elderly. Can J Publ Health 1988; 79: 175–180
  • McBean A M, Babish J D, Warren J L. The impact and cost of influenza in the elderly. Arch Intern Med 1993; 153: 2105–2111
  • Nichol K L, Margolis K L, Wuorenma J, von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. ‘New Engl J Med 1994; 331: 778–784
  • Govaert T ME, Thijis C TMCN, Masurel N, Sprenger M JW, Dinant G J, Knottnerus J A. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA 1994; 272: 1661–1665
  • Pyhälä R, Kleemola M, Kumpulainen V, Vartiainen E, Lappi S, Pönkä A, Cantell K. Immune response to inactivated influenza virus vaccine: antibody reactivity with epidemic influenza B viruses of two highly distinct evolutionary lineages. Vaccine 1992; 10: 631–636
  • Influenza in Finland. 22nd May 1991. Bulletin of the National Public Health Institute, Finland
  • Kekki P, Kupiainen O. Lääkärilakko. University of Helsinki, Depaitment of Primary Care, Publications no. 2. 1985

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.